Top compounds associated with response to INTS4


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA Salubrinal GDSC1000 pan-cancer AAC -0.071 0.2
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA AC220 GDSC1000 pan-cancer AAC -0.043 0.2
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.038 0.2
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA BX-795 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA VX-11e GDSC1000 pan-cancer AAC 0.041 0.2
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.041 0.2
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.055 0.2
Download CSV